Literature DB >> 26446473

Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles.

Adam Bohr1, Jorrit Water, Moritz Beck-Broichsitter, Mingshi Yang.   

Abstract

Nanoparticle-based pharmaceutical products are currently finding their way onto the market as a popular strategy to improve the therapeutic efficacy of numerous drugs, hereunder medications for a targeted treatment of severe diseases (e.g., cancer). Drug-loaded polymer and lipid nanoparticles are typically produced via solvent-based methods and result in colloidal suspensions, which often suffer from physical and chemical instability (e.g., formation of aggregates) resulting in loss of functionality. There are various ways to stabilize such nanoparticle-based formulations including addition of ionic materials to provide electrostatic repulsion or polymer materials forming a steric barrier between the particles. However, for long-term stability often water needs to be removed to obtain a dry product. For this purpose atomization-based techniques such as spray-drying and spray freeze-drying are frequently used to remove water from the nanoparticle suspensions and to form tailored powder products (e.g., nanoembedded microparticles (NEMs)). NEMs provide an excellent vehicle for both stabilization of nanoparticles and delivery of the nanoparticles to their intended site of action. Excipients such as sugars and biocompatible polymers are used to prepare the surrounding, stabilizing matrix. Further, these "Trojan" vehicles are compatible with a wide range of therapeutic molecules, nanocarriers and applications for different routes of administration. The preparation, properties and stability of these NEMs are described in this review and their application and future development are discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26446473     DOI: 10.2174/1381612821666151008124322

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

Review 1.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors:  Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

Review 2.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

3.  Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.

Authors:  Shihui Yu; Xiaohui Pu; Maizbha Uddin Ahmed; Heidi H Yu; Tarun Tejasvi Mutukuri; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2021-10-06       Impact factor: 5.875

4.  Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.

Authors:  Jaleh Varshosaz; Somayeh Taymouri; Hamed Hamishehkar; Razieh Vatankhah; Shadi Yaghubi
Journal:  Res Pharm Sci       Date:  2017-06

5.  Chitosan-Based Nano-Embedded Microparticles: Impact of Nanogel Composition on Physicochemical Properties.

Authors:  Paromita Islam; Jorrit J Water; Adam Bohr; Jukka Rantanen
Journal:  Pharmaceutics       Date:  2016-12-22       Impact factor: 6.321

Review 6.  Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.

Authors:  You Xu; Aneesh Thakur; Yibang Zhang; Camilla Foged
Journal:  Pharmaceutics       Date:  2021-01-28       Impact factor: 6.321

7.  Assessing the potential use of chitosan scaffolds for the sustained localized delivery of vitamin D.

Authors:  Archana A Gupta; Supriya Kheur; Ravindra V Badhe; A Thirumal Raj; Ramesh Bhonde; Amit Jaisinghani; Nishant Vyas; Vikrant R Patil; Yaser Ali Alhazmi; Sameena Parveen; Hosam Ali Baeshen; Shankargouda Patil
Journal:  Saudi J Biol Sci       Date:  2021-01-20       Impact factor: 4.219

Review 8.  Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections.

Authors:  Zheng Huang; Sylvia Natalie Kłodzińska; Feng Wan; Hanne Mørck Nielsen
Journal:  Drug Deliv Transl Res       Date:  2021-03-10       Impact factor: 4.617

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.